Herbert Fountain is currently developing the next generation of anti-aging therapies and senescent cell diagnostics as a PhD student in the Biological & Biomedical Sciences program at Cornell University. The goal of his research is to create safer senolytics while also validating a new, single-cell, marker-free age-related pathology detection method. Herbert is passionate about longevity-science communication and hopes to contribute to a world in which all people can live healthier and longer lives.